Experimental group | Days after VACV inj. | Â | Â | Â | Â |
---|---|---|---|---|---|
VACGLa 520445F, Affymetrix platform | VACV only | Permutation | House keeping (human/mouse) | Permutation | |
(cut off p2-value < 0.005 (unpaired Student t test) |  | (∑ 219) | test p-value | (∑ 337) | test p-value |
GI-101A | 7 | 0 | N.S. | 3 | N.S. |
GI-101A | 21 | 219 | < 0.001 | (232) | < 0.001 |
GI-101A | 42 | 216 | < 0.001 | (237) | < 0.001 |
HT-29 | 21 | 0 | N.S. | (3) | N.S. |
HT-29 | 42 | 0 | N.S. | (10) | N.S. |
37 K whole genome HUMAN array | Â | All genes | Permutation | Â | Â |
(cut off p2-value < 0.001 (unpaired Student t test) |  | (∑ 37 K) | test p-value |  |  |
GI-101A | 21 | 136 | < 0.05 | Â | Â |
GI-101A | 42 | 91 | < 0.05 | Â | Â |
HT-29 | 21 | 4 | N.S. | Â | Â |
HT-29 | 42 | 10 | N.S. | Â | Â |
37 K whole genome Mouse array | Â | All genes | Permutation | Â | Â |
(cut off p2-value < 0.001 (unpaired Student t test) |  | (∑ 37 K) | test p-value |  |  |
GI-101A | 21 | 105 | < 0.05 | Â | Â |
GI-101A | 42 | 1026 | < 0.001 | Â | Â |
HT-29 | 21 | 7 | N.S. | Â | Â |
HT-29 | 42 | 14 | N.S. | Â | Â |